Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dechu Puliyanda

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Paediatric Drugs|October 12, 2007
Induction therapy in pediatric renal transplant recipients: an overviewAsha Moudgil, Dechu Puliyanda
The New England Journal of Medicine|December 31, 2005
Passive immunization against cytomegalovirus during pregnancyNeil S Silverman, Dechu Puliyanda, Debbie Lehman
Kidney International|May 25, 2018
Collagen type III glomerulopathyHelen P Pizzo, Mark Haas, Dechu Puliyanda
Pediatric Transplantation|April 30, 2025
Low Incidence of Rejection and De Novo Donor-Specific Antibody Formation Following COVID-19 Vaccination or Infection Among Pediatric Kidney Transplant RecipientsHelen Pizzo, Jonathan Garrison, Kelly Kirshner, et al.
Transplantation|July 16, 2014
The authors' replyJoseph Kahwaji, Stanley Jordan, Dechu Puliyanda, et al.
Pediatric Nephrology (Berlin, Germany)|October 13, 2025
A rare case of hyperuricemia and acute kidney injury in a kidney transplant patientAnna S Nidhiry, Dechu Puliyanda, Cindy Blifeld, et al.
Pediatric Nephrology (Berlin, Germany)|December 12, 2025
Equitable access to pediatric kidney transplantation: bridging the gap-the view from low- to lower-middle-income countriesKinnari Vala, Shahenaz Kapadia, Asiri Abeyagunawardena, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
Cellular immune responses to cytomegalovirus in renal transplant recipientsRaju Radha, Stanley Jordan, Dechu Puliyanda, et al.
Pediatric Nephrology (Berlin, Germany)|September 8, 2014
The effects of everolimus on tuberous sclerosis-associated lesions can be dramatic but may be impermanentJoseph M Miller, Ashley Wachsman, Katherine Haker, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2022
Failure to thrive in an 8-month-old female: QuestionsRomina Kim, XinYi Ye, Pedro A Sanchez-Lara, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Paediatric Drugs|October 12, 2007
Induction therapy in pediatric renal transplant recipients: an overviewAsha Moudgil, Dechu Puliyanda
The New England Journal of Medicine|December 31, 2005
Passive immunization against cytomegalovirus during pregnancyNeil S Silverman, Dechu Puliyanda, Debbie Lehman
Kidney International|May 25, 2018
Collagen type III glomerulopathyHelen P Pizzo, Mark Haas, Dechu Puliyanda
Pediatric Transplantation|April 30, 2025
Low Incidence of Rejection and De Novo Donor-Specific Antibody Formation Following COVID-19 Vaccination or Infection Among Pediatric Kidney Transplant RecipientsHelen Pizzo, Jonathan Garrison, Kelly Kirshner, et al.
Transplantation|July 16, 2014
The authors' replyJoseph Kahwaji, Stanley Jordan, Dechu Puliyanda, et al.
Pediatric Nephrology (Berlin, Germany)|October 13, 2025
A rare case of hyperuricemia and acute kidney injury in a kidney transplant patientAnna S Nidhiry, Dechu Puliyanda, Cindy Blifeld, et al.
Pediatric Nephrology (Berlin, Germany)|December 12, 2025
Equitable access to pediatric kidney transplantation: bridging the gap-the view from low- to lower-middle-income countriesKinnari Vala, Shahenaz Kapadia, Asiri Abeyagunawardena, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|January 8, 2005
Cellular immune responses to cytomegalovirus in renal transplant recipientsRaju Radha, Stanley Jordan, Dechu Puliyanda, et al.
Pediatric Nephrology (Berlin, Germany)|September 8, 2014
The effects of everolimus on tuberous sclerosis-associated lesions can be dramatic but may be impermanentJoseph M Miller, Ashley Wachsman, Katherine Haker, et al.
Pediatric Nephrology (Berlin, Germany)|October 31, 2022
Failure to thrive in an 8-month-old female: QuestionsRomina Kim, XinYi Ye, Pedro A Sanchez-Lara, et al.
Pageof 3